COVID-19: Investigational Drugs and Other Therapies


Novel (COVID-19 or 2019-nCoV or SARS-CoV-2), which abruptly arose in December 2019 is as yet frequenting the whole human race and has influenced not just the medical care framework yet additionally the worldwide financial equilibriums. Corona virus was immediately assigned as a worldwide pandemic by the World Health Organization as there have been about 98.0 million affirmed cases and about 2.0 million affirmed passing, as of January 2021. In spite of the fact that, our comprehension of COVID-19 has altogether expanded since its episode, and various treatment draws near and pharmacological mediations have been tried or are right now being worked on to alleviate its danger factors.



As of late, some antibody applicants appeared around 95% clinical viability, and now accepting crisis use endorsements in various nations. US FDA as of late endorsed BNT162 and mRNA-1273 immunizations created by Pfizer/BioNTech and Moderna Inc. for crisis use and immunization in the USA. In this audit, we present a compact outline of the SARS-CoV-2 infection structure, atomic systems of contamination, COVID-19 the study of disease transmission, finding, and clinical appearances. We moreover arrange distinctive treatment methodologies and clinical preliminaries started after the pandemic flare-up, in light of viral contamination and replication components. Moreover, we surveyed the novel pharmacological mediation approaches and antibody improvement systems against COVID-19. We guess that the current pandemic crisis will trigger itemized investigations of Covids, their component of contamination, advancement of efficient medication repurposing approaches, and novel medication disclosures for current and future pandemic episodes.



 


  • SARS-CoV-2 Virus Structure and Integration
  • SARS-CoV-2 Virus Receptor Mechanism
  • Clinical Manifestation
  • Binding Antibody Detection Methods
  • Potential Treatment Strategies

Related Conference of COVID-19: Investigational Drugs and Other Therapies

April 04-05, 2024

17th European Biosimilars Congress

Madrid, Spain
April 11-12, 2024

5th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

COVID-19: Investigational Drugs and Other Therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in